ASX Announcements
Issued Capital - Other
Application for quotation of securities - EBO
Appendix 2A (Application for Quotation of Securities)
Issued Capital - Other
Notification of cessation of securities - EBO
Appendix 3H (Notification of cessation of securities)
Issued Capital - Other
February
TPG’s $3.75b pets-and-vets biz Greencross weighs life on the ASX
There are still a few pieces to fall in place, including key appointments, before TPG’s Asia boss Joel Thickins can make a final decision on an IPO.
November 2024
Greencross names new CEO as TPG eyes exit path
The new chief executive of the vet clinics and Petbarn and City Farmers pet stores arrives amid intense competition from Woolworths and other big retailers.
October 2024
Ebos CEO takes swing at $8.8b Chemist Warehouse-Sigma deal
The chief executive of the pharmacy group behind TerryWhite Chemmart says the merger, being assessed by the competition regulator, would harm the health network.
December 2023
Chemist Warehouse heads for the ASX via Sigma deal
The billionaire Gance and Verrocchi families are eyeing an ASX berth through a reverse listing of their retail behemoth via Sigma Healthcare.
November 2023
Inside the $4b Greencross bellyflop – and what it means for deals
Someone has cooked the golden goose, and fingers are pointing at underwriters, investors, private equity and advisers, after last week’s spectacular blow up.
Greencross’ $3.75b deal with EBOS dumped as investors lose bite
The deal would have allowed EBOS to plunge deeper into pet care, after losing a key chemist supply contract.
EBOS in $3.75 billion deal to buy Greencross; Macquarie, UBS on raise
It’s down to the short strokes at ASX-listed pharma distributor EBOS’s tilt for TPG Capital’s pets and vets business Greencross.
June 2023
Sigma Healthcare wins EBOS’s Chemist Warehouse contract
Sigma Pharmaceuticals has won over the Chemist Warehouse wholesale pharmaceuticals contract held by its rival EBOS.
December 2021
EBOS buys PEP’s Lifehealthcare, raising $742m
Australasian health care group EBOS has acquired medical devices business Lifehealthcare for $1.167 billion, and is asking shareholders to tip into a $742 million raising to help fund it.
August 2021
Ebos Group posts record 2021 result
Ebos Group has posted another record result for the 2021 financial year, announcing double-digit earnings growth, and an $80 million pet food manufacturing facility.
July 2021
Wesfarmers’ API bid could be the start of a fresh shopping spree
The $1.38 a share cash offer for Priceline owner API was classic Wesfarmers modus operandi, and was timed to perfection.
June 2021
How investors can play the booming pet trade
The billions of dollars Australians spend on caring for and feeding their ‘fur babies’ is likely to have increased strongly over the past 18 months and is expected to continue.
February 2021
All the key profit results for February 17
On the biggest day yet of the interim profit reporting season we have results from Coles, Westpac, Treasury Wines, Tabcorp, Charter Hall, Corporate Travel, Domino’s Pizza, Carsales, TPG, Super Retail Group, Netwealth, Asaleo Care, Bapcor, Pro Medicus, Pact Group, EBOS and McPherson’s. Find full reports and analysis here.
Pet care helps EBOS to record profit
The wholesaler and distributor of healthcare, medical and pharmaceutical products increased its interim dividend and painted an upbeat outlook.
August 2020
EBOS Group posts record earnings and profits
The wholesaler and distributor of healthcare, medical and pharmaceutical products gained from its new contract with pharmacy giant Chemist Warehouse.
June 2020
Strategic bails on EBOS, Citi lines up fundies for $300m stake
Stockbrokers Citi and Forsyth Barr were in the market with a big parcel of shares in EBOS Group late on Monday.
Government, pharmacies strike $1.2b deal on PBS
The new deal provides certainty for the nation's 5,800 community pharmacies and will result in improved medication management and adherence programs and better access to over 200 million subsidised prescriptions each year.
November 2019
UBS in EBOS Holdings block trade, Sybos selling
UBS' equities desk is in the market with a large block of EBOS shares on Monday afternoon.
April 2019
EBOS placement upsized ahead of book close
Dual-listed health care supplies company EBOS Group has upsized its equity raising, following response from investors.
EBOS fronts funds for $NZ150m equity injection
Kiwi health care supplies company EBOS is in front of fund managers seeking a $NZ150 million equity injection.